Get Flat 15% Discount on ED Drugs for orders value $70 or more
  • Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      India's Ranbaxy gets final US FDA approval for cetirizine hydrochloride tablets


      MUMBAI, Dec. 31, 2007 (Thomson Financial delivered by Newstex) -- India's Ranbaxy Laboratories Ltd said it received final approval from the US Food and Drug Administration (US FDA) to manufacture and market allergic drug Cetirizine hydrochloride tablets in the US.

      The company said the approval is for over the counter sales of the tablets in strengths of 5 mg and 10 mg.

      In a filing with the Bombay (OOTC:BBAO) Stock Exchange, Ranbaxy said cetirizine tablets are the generic version of Pfizer Inc's (NYSE:PFE) Zyrtec and used for temporary relief from runny nose, sneezing, itching of the nose or throat, and itchy, watery eyes due to hay fever or other upper respiratory Allergies.

      The total annual market sales for cetirizine hydrochloride tablets as a prescription only product were 1.3 bln usd for the 12 months to end-September, the company said.

      Copyright Thomson Financial News Limited 2007. All rights reserved.

      The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.

      December 31, 2007


      Share this Article!

    Back to top^